(no title)
Uberphallus | 4 years ago
A lot of cash was dumped into fast and extensive R&D, trials and production scaling because of the urgency of the situation, and along comes an insane documentation backlog.
To put in perspective, the original HPV vaccine R&D and trial spanned over 7 years with 25,000 patients (of which only 20,000 women), and assuming the documentation was provided to the FDA as it was produced, it could be FOIA'd relatively quickly.
Pfizer/BioNTech did the same, with almost double the patients, in just over 6 months.
No comments yet.